Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis
Cut-off
Kappa
Roche Diagnostics
DOI:
10.3389/fimmu.2024.1385231
Publication Date:
2024-04-30T05:07:26Z
AUTHORS (7)
ABSTRACT
Background Cerebrospinal fluid (CSF) kappa free light chain (κFLC) measures gained increasing interest as diagnostic markers in multiple sclerosis (MS). However, the lack of studies comparing assay-dependent cutoff values hinders their use clinical practice. Additionally, optimal κFLC parameter for identifying MS remains a subject ongoing debate. Objectives The aim this study was to compare same-sample accuracies index, κIgG CSF κFLC/IgG ratio, and isolated (iCSF-κFLC) between two reference centers using different methods. Methods Paired serum samples were analyzed albumin concentrations by Freelite ® -Optilite (Sint-Jan Bruges hospital) N Latex -BNII (Ghent University hospital). Diagnostic performance differentiate from controls assessed ROC curve analysis. Results A total 263 participants included (MS, n = 80). Optimal index (Freelite -Optilite: 7.7; -BNII: 4.71), 14.15, 12.19), ratio 2.27; 1.44) differed Sensitivities related 89.9% -Optilite) versus 94.6% (N -BNII) 91% 92.2% 81.3% 91.4% ratio. iCSF-κFLC, (0.36 mg/L) specificities (81.8%) identical with sensitivity 90.5% -BNII. [area under (AUC) 0.924; 0.962] (AUC 0.929; 0.961) superior compared oligoclonal bands (AUC: 0.898, sensitivity: 83.8%, specificity: 95.9%). Conclusions seem be excellent MS, irrespective method used quantification. Based on AUC, they appear choice. For all measures, methods except iCSF-κFLC. iCSF-κFLC might therefore serve method-independent, more cost-efficient, initial screening measure MS. These findings are particularly relevant practice given potential future implementation intrathecal synthesis criteria multicentre pooling data measures.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (50)
CITATIONS (3)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....